300858.SZ
科拓生物
SZSE · Healthcare · C 制造业 · CN
CNY 14.55
−5.52%Sep 3, 2026, 08:47 UTC
Kebot Bio announced that as of August 31, 2026, it had repurchased 4.7876 million shares for approximately 70 million yuan under its ongoing buyback program.
Aug 24, 2026, 10:59 UTC
Kebotu Bio announced that shareholder Ningbo Shunyi reduced its stake by 0.65% (1.7001 million shares) via centralized bidding, completing its reduction plan, while Ningbo Kehuida did not reduce shares.
Source: